U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086937) titled 'Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children' on July 17.

Brief Summary: This study aimed at comparing the efficacy of nitazoxanide-based triple therapy versus standard triple therapy for eradication of Helicobacter pylori infection in children at a tertiary care hospital.

Study Start Date: Jan. 01

Study Type: INTERVENTIONAL

Condition: Helicobacter Pylori Infection

Intervention: DRUG: Nitazoxanide

Children were given nitazoxanide, PPI, and clarithromycin for 14 days.

DRUG: Metronidazole

Children received MTZ, PPI, and clarithromycin for 14 days.

DRUG: PPI

Children were given om...